Potential Benefit of Rituximab in Rhupus Patients From a Single-Center: A Series of 16 Cases.

Pascal Rottenberg,Pauline Brevet,Mathilde Leclercq,Fabienne Jouen,Isabelle Marie,Hervé Lévesque,Thierry Lequerré,Olivier Vittecoq

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases（2022）

引用 0|浏览8

暂无评分

摘要

In rhupus refractory to conventional treatment, T or B lymphocytes targeted therapies, and particularly rituximab, seem to be a relevant therapeutic option unlike anticytokine biologics.

查看译文

关键词

rhupus syndrome,rheumatoid arthritis,systemic lupus erythematosus,treatment,biologic DMARD,rituximab,abatacept,joint involvement

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要